Bio
Dr. Klempin earned a PhD in neurobiology from Humboldt University of Berlin in 2008. She completed
postdoctoral training at Chicago Medical School and the UW in Seattle. In 2014, she became a Principal Investigator at the Max Delbrück Center in Berlin, working with Dr. M. Bader. She was a Rahel Hirsch Program fellow at Charité University
and completed her habilitation in 2020. Dr. Klempin is a member of SfN and APS, has lectured at IKBFU in Kaliningrad, and was a visiting professor at Unifesp in São Paulo. Her research focuses on serotonin and the intersection of brain and periphery. Outside of research, she enjoys dancing and photography.
Education
2020 – Habilitation. Experimental Psychiatry
Charité University Medicine Berlin, Germany
2008 – Ph.D. Neurobiology
Humboldt University of Berlin, Germany
2003 – M.Sc. Biology
Humboldt University of Berlin, Germany
Affiliated Hospitals & Clinics
Cras tincidunt lectus ac quam ultrices posuere. Duis pretium commodo risus vel posuere.
Sed elit dolor, dapibus vel sapien vel, rutrum malesuada diam.
Research
My research explores the intersection of brain and periphery through “system-level
neuroscience,” focusing on local mediators such as serotonin, brain-derived neurotrophic
factor (BDNF), and the renin-angiotensin system (RAS), as well as non-local cues like
physical exercise. I study how these signaling factors influence neuroplasticity,
particularly in the hippocampus. I discovered that serotonin mediates exercise-induced
neurogenesis and that circulatory factors, specifically ACE2, influence serotonin
metabolism, linking physical activity to brain circuitry formation. These findings
highlight how changes in activity at the system level regulate both vascular and neurogenic
homeostasis.
I also investigate how microglia and inflammation affect neuroplasticity and contribute
to disease progression. Chronic inflammation, linked to heart failure, can promote
neurodegeneration and impair metabolic processes, further impacting brain function.
Using genetic tools, optogenetics, and behavioral models, I aim to uncover pathways
that regulate neuroplasticity, offering potential targets for treating mood disorders
and improving brain health.
